May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
Psilopatis I, Karniadakis I, Danos KS, Vrettou K, Michaelidou K, Mavridis K, Agelaki S, Theocharis S.
Psilopatis I, et al. Among authors: agelaki s.
Int J Mol Sci. 2022 Dec 21;24(1):93. doi: 10.3390/ijms24010093.
Int J Mol Sci. 2022.
PMID: 36613532
Free PMC article.
Review.